Generalized Pustular Psoriasis
📧 Sign up to get email alerts when something new happens for Generalized Pustular Psoriasis.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2024-03-18FDA Approved: SPEVIGO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for SPEVIGO (spesolimab-sbzo) to update its labeling following initial approval.